Bio-Rad Laboratories BIO Clinical Diagnostics — Net Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories's clinical diagnostics — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories's clinical diagnostics — net sales?
- Bio-Rad Laboratories (BIO) reported clinical diagnostics — net sales of $363.6M in Q1 2026.
- How has Bio-Rad Laboratories's clinical diagnostics — net sales changed year-over-year?
- Bio-Rad Laboratories's clinical diagnostics — net sales increased by 1.9% year-over-year, from $356.8M to $363.6M.
- What is the long-term trend for Bio-Rad Laboratories's clinical diagnostics — net sales?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories's clinical diagnostics — net sales has grown at a 0.8% compound annual growth rate (CAGR), from $1.52B to $1.56B.
- What does clinical diagnostics — net sales mean?
- Total revenue earned from the diagnostics business segment.
- How do you interpret clinical diagnostics — net sales?
- Higher sales indicate strong market demand and successful commercial execution in the diagnostics market.
- How does clinical diagnostics — net sales compare across companies?
- A core performance metric for all life science and diagnostics companies.